KMT2A and acute myeloid leukemia: Somatic mutations in genes regulating epigenetic modifications, such as IDH, TET2, DNMT3A, ASXL1, EZH2 and KMT2A are frequently detected in patients with AML, especially those with intermediate-risk cytogenetics [19, 76–80].